My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2021-041
CBCC
>
Resolutions
>
2020's
>
2021
>
2021-041
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
6/29/2021 9:51:39 AM
Creation date
6/28/2021 2:13:16 PM
Metadata
Fields
Template:
Resolutions
Resolution Number
2021-041
Approved Date
06/15/2021
Agenda Item Number
8.G.
Resolution Type
Opiod Litigation
Entity Name
State of Florida
Subject
Authorization to join with the State and other local governments in a Memorandum of Understanding
(MOU) for a unified plan (the Florida Plan) for allocation of settlement funds
to abate and resolve the opioid epidemic (ref 2021-)
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
31
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
mental health needs in young people that (when not properly addressed) increase the risk of opioid or <br />other drug misuse. <br />H. PREVENT OVERDOSE DEATHS AND OTHER HARMS (HARM REDUCTION) <br />Support efforts to prevent or reduce overdose deaths or other opioid -related harms through evidence - <br />based or evidence -informed programs or strategies that may include, but are not limited to, the <br />following: <br />1. Increase availability and distribution of naloxone and other drugs that treat overdoses for first <br />responders, overdose patients, individuals with OUD and their friends and family members, individuals <br />at high risk of overdose, schools, community navigators and outreach workers, persons being released <br />from jail or prison, or other members of the general public. <br />2. Public health entities provide free naloxone to anyone in the community <br />3. Training and education regarding naloxone and other drugs that treat overdoses for first responders, <br />overdose patients, patients taking opioids, families, schools, community support groups, and other <br />members of the general public. <br />4. Enable school nurses and other school staff to respond to opioid overdoses, and provide them with <br />naloxone, training, and support. <br />5. Expand, improve, or develop data tracking software and applications for overdoses/naloxone <br />revivals. <br />6. Public education relating to emergency responses to overdoses. <br />7. Public education relating to immunity and Good Samaritan laws. <br />8. Educate first responders regarding the existence and operation of immunity and Good Samaritan <br />laws. <br />9. Syringe service programs and other evidence -informed programs to reduce harms associated with <br />intravenous drug use, including supplies, staffing, space, peer support services, referrals to treatment, <br />fentanyl checking, connections to care, and the full range of harm reduction and treatment services <br />provided by these programs. <br />10. Expand access to testing and treatment for infectious diseases such as HIV and Hepatitis C resulting <br />from intravenous opioid use. <br />11. Support mobile units that offer or provide referrals to harm reduction services, treatment, recovery <br />supports, health care, or other appropriate services to persons that use opioids or persons with OUD and <br />any co-occurring SUD/MH conditions. <br />12. Provide training in harm reduction strategies to health care providers, students, peer recovery <br />coaches, recovery outreach specialists, or other professionals that provide care to persons who use <br />opioids or persons with OUD and any co-occurring SUD/MH conditions. <br />13. Support screening for fentanyl in routine clinical toxicology testing. <br />10 <br />
The URL can be used to link to this page
Your browser does not support the video tag.